Clinical skills or high-tech MR in TIA patients: what makes the difference?

Riccardo Altavilla; Sabrina Anticoli; Michele Venti; Monica Acciarresi; Andrea Alberti; Valeria Caso; Cataldo D’Amore; Francesca Romana Pezzella; Michele Venti; Giancarlo Agnelli; Maurizio Paciaroni

doi:10.1007/s10072-018-3546-4

Related publications

Article2023

Clinical Associations and Prognostic Value of MRI-Visible Perivascular Spaces in Patients With Ischemic Stroke or TIA

Jonathan G. Best, Gareth Ambler, Duncan Wilson, Houwei Du, Keon‐Joo Lee, Jae‐Sung Lim, Kay Cheong Teo, Henry Ma, Young Dae Kim, Tae‐Jin Song, Derya Selçuk Demirelli, Masashi Nishihara, Masaaki Yoshikawa, Marta Kubacka, Annaelle Zietz, Rustam Al‐Shahi Salman, Hans Rolf Jäger, Professor Gregory Lip, Leonidas D Panos, Martina Goeldlin, Lee‐Anne Slater, Christopher Karayiannis, Thanh G. Phan, Maximilian Bellut, Jill Abrigo, Cyrus Cheng, Thomas Leung, Chiu‐Wing Winnie Chu, Francesca M. Chappell, Stephen Makin, Dianne H.K. van Dam-Nolen, M. Eline Kooi, Sebastian Köhler, Julie Staals, Grégory Kuchcinski, Régis Bordet, Florian Dubost, Joanna M. Wardlaw, Yannie Soo, Felix Fluri, Velandai Srikanth, Simon Jung, Nils Peters, Hideo Hara, Yusuke Yakushiji, Dilek Neci̇oğlu Örken, Ji Hoe Heo, Kui Kai Lau, Hee‐Joon Bae, David J. Werring

Article2007

Theoretical bioinorganic chemistry: the electronic structure makes a difference

Barbara Kirchner, Frank Wennmohs, Shengfa Ye, Frank Neese

Current Opinion in Chemical Biology

Article2022

Early use of high-efficacy disease‑modifying therapies makes the difference in people with multiple sclerosis: an expert opinion

Massimo Filippi, Maria Pia Amato, Diego Centonze, Paolo Gallo, Claudio Gasperini, Matilde Inglese, Francesco Patti, Carlo Pozzilli, Paolo Preziosa, María Trojano

Article1997

Singlet−Triplet Splittings and 1,2-Hydrogen Shift Barriers for Methylphenylborenide, Methylphenylcarbene, and Methylphenylnitrenium in the Gas Phase and Solution. What a Difference a Charge Makes

Christopher J. Cramer, Donald G Truhlar, Daniel E. Falvey

Corrigendum2022

Correction to: Early use of high-efficacy disease-modifying therapies makes the difference in people with multiple sclerosis: an expert opinion